Top Markets
Coin of the day
Fusion Antibodies plc Fusion Antibodies plc

Fusion Antibodies plc

FAB
Rangering i aksjer #20442
Fusion Antibodies plc, a contract research organization, engages in the... Fusion Antibodies plc, a contract research organization, engages in the research, development, and manufacture of recombinant proteins and antibodies primarily for cancer and infectious diseases in the United Kingdom, the rest of Europe, North America, and internationally. It offers monoclonal antibody discovery and development, antibody sequencing, antibody engineering, antibody humanization and rational affinity maturation platform, recombinant protein expression, and stable cell line development and cGMP scale up services. The company serves pharmaceutical, biotech, and diagnostic companies. It has a collaboration partnership with Celonic AG. Fusion Antibodies plc was incorporated in 2000 and is headquartered in Belfast, the United Kingdom.
Aksjekurs
$0.16328419
Markedsverdi
$204.14K
Endring (1 dag)
4.35%
Endring (1 år)
102.45%
Land
GB
Handel Fusion Antibodies plc (FAB)

Kategori

Aksjeprishistorikk for Fusion Antibodies plc (FAB)
Høyeste sluttskurs: $0.17 den 2026-03-01

Laveste sluttskurs: $2.40 den 2017-12-01
Aksjeprishistorikk for Fusion Antibodies plc fra 2017 til 2026
Årlig aksjeprisytelse
År Ytelse
2026 (TTM) -21.78%
2025 153.61%
2024 38.42%
2023 -88.93%
2022 -66.99%
2021 -1.91%
2020 55.79%
2019 51.91%
2018 -71.85%
2017 0.00%
Aksjepris for lignende selskaper eller konkurrenter
Selskap Aksjepris Endring 1år% Land
$36.82 -51.12%
DK
$451.24 -11.82%
US
$736.53 11.43%
US
$294.88 52.33%
BE
$681.85 12.16%
NL